Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 2;14(1):45.
doi: 10.1186/s13024-019-0346-0.

Organotypic brain slice cultures to model neurodegenerative proteinopathies

C L Croft  1   2 , H S Futch  1   2 , B D Moore  1   2 , T E Golde  3   4   5
Affiliations
Review

Organotypic brain slice cultures to model neurodegenerative proteinopathies

C L Croft et al. Mol Neurodegener. .

Abstract

Organotypic slice cultures of brain or spinal cord have been a longstanding tool in neuroscience research but their utility for understanding Alzheimer's disease (AD) and other neurodegenerative proteinopathies has only recently begun to be evaluated. Organotypic brain slice cultures (BSCs) represent a physiologically relevant three-dimensional model of the brain. BSCs support all the central nervous system (CNS) cell types and can be produced from brain areas involved in neurodegenerative disease. BSCs can be used to better understand the induction and significance of proteinopathies underlying the development and progression of AD and other neurodegenerative disorders, and in the future may serve as bridging technologies between cell culture and in vivo experiments for the development and evaluation of novel therapeutic targets and strategies. We review the initial development and general use of BSCs in neuroscience research and highlight the advantages of these cultures as an ex vivo model. Subsequently we focus on i) BSC-based modeling of AD and other neurodegenerative proteinopathies ii) use of BSCs to understand mechanisms underlying these diseases and iii) how BSCs can serve as tools to screen for suitable therapeutics prior to in vivo investigations. Finally, we will examine i) open questions regarding the use of such cultures and ii) how emerging technologies such as recombinant adeno-associated viruses (rAAV) may be combined with these models to advance translational research relevant to neurodegenerative disorders.

Keywords: Alzheimer’s disease; Amyloid-β; Microglia; Neurodegeneration; Organotypic brain slice cultures; Proteinopathies; Recombinant adeno-associated virus; Tau.

PubMed Disclaimer

Conflict of interest statement

TEG is a founder of Lacerta Therapeutics.

References

    1. Humpel C. Organotypic brain slice cultures: a review. Neuroscience. 2015;305:86–98. doi: 10.1016/j.neuroscience.2015.07.086. - DOI - PMC - PubMed
    1. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, et al. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat Naurosci. 2014;17(1):131–143. doi: 10.1038/nn.3599. - DOI - PMC - PubMed
    1. Arber C, Lovejoy C, Wray S. Stem cell models of Alzheimer's disease: progress and challenges. Alz Res Ther. 2017;9(1):42. doi: 10.1186/s13195-017-0268-4. - DOI - PMC - PubMed
    1. Fitzjohn SM, Doherty AJ, Collingridge GL. The use of the hippocampal slice preparation in the study of Alzheimer's disease. Eur J Pharm. 2008;585(1):50–59. doi: 10.1016/j.ejphar.2008.02.077. - DOI - PubMed
    1. Gähwiler BH. Organotypic monolayer cultures of nervous tissue. J Neurosci Methods. 1981;4(4):329–342. doi: 10.1016/0165-0270(81)90003-0. - DOI - PubMed

Publication types